Trade Summary

1 week ago, Westlake Biopartners Opportunity Fund I, L.P., serving as 10% owner at Kyverna Therapeutics, Inc. (KYTX), purchased 133,333 shares at $7.50 per share, for a total transaction value of $999,998.00. Following this transaction, Westlake Biopartners Opportunity Fund I, L.P. now holds 4,657,257 shares of KYTX.

This purchase represents a 3.00% increase in Westlake Biopartners Opportunity Fund I, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, December 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 4 days after the trade was made.

Kyverna Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.